These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18057979)
1. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population. Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. Xin XY; Ding JQ; Chen SD J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606 [TBL] [Abstract][Full Text] [Related]
3. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330 [TBL] [Abstract][Full Text] [Related]
4. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients. Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193 [TBL] [Abstract][Full Text] [Related]
5. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981 [TBL] [Abstract][Full Text] [Related]
6. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931 [TBL] [Abstract][Full Text] [Related]
7. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms. Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889 [TBL] [Abstract][Full Text] [Related]
8. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690 [TBL] [Abstract][Full Text] [Related]
9. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease. Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? Thome J; Gewirtz JC; Sakai N; Zachariou V; Retz-Junginger P; Retz W; Duman RS; Rösler M Neurosci Lett; 1999 Oct; 274(1):37-40. PubMed ID: 10530514 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E. Corbo RM; Scacchi R; Vilardo T; Ruggeri M Clin Chem Lab Med; 2001 Jan; 39(1):2-6. PubMed ID: 11256794 [TBL] [Abstract][Full Text] [Related]
12. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population. Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients. Zill P; Engel R; Hampel H; Behrens S; Bürger K; Padberg F; Stübner S; Möller HJ; Ackenheil M; Bondy B Eur Arch Psychiatry Clin Neurosci; 2001; 251(1):24-8. PubMed ID: 11315514 [TBL] [Abstract][Full Text] [Related]
15. Association between ε2/3/4, promoter polymorphism (-491A/T, -427T/C, and -219T/G) at the apolipoprotein E gene, and mental retardation in children from an iodine deficiency area, China. Li J; Zhang F; Wang Y; Wang Y; Qin W; Xing Q; Qian X; Guo T; Gao X; He L; Gao J Biomed Res Int; 2014; 2014():236702. PubMed ID: 24790992 [TBL] [Abstract][Full Text] [Related]
17. Association study of apolipoprotein E promoter polymorphism (-427 T/C) and Alzheimer's disease in a Tunisian population. Achouri-Rassas A; Ben Ali N; Fray S; Kechaou M; Oudiaa Zakraoui N; Hadj-Fredj S; Cherif A; Anane N; Echebi S; Messaoud T; Belal S Rev Neurol (Paris); 2016 Feb; 172(2):127-31. PubMed ID: 26563666 [TBL] [Abstract][Full Text] [Related]
18. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578 [TBL] [Abstract][Full Text] [Related]
19. The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia. Trebunová M; Slabá E; Habalová V; Gdovinová Z J Neural Transm (Vienna); 2009 Mar; 116(3):339-44. PubMed ID: 19142571 [TBL] [Abstract][Full Text] [Related]